Irritable bowel syndrome in office-based practice in the United States.
about
Do published guidelines for evaluation of irritable bowel syndrome reflect practice?Prevalence of irritable bowel syndrome: a community survey.Diet in irritable bowel syndromeTreatments for irritable bowel syndrome: patients' attitudes and acceptabilityChronic non-specific abdominal complaints in general practice: a prospective study on management, patient health status and course of complaints.Effect of probiotics on symptoms in korean adults with irritable bowel syndrome.Dietary fiber in irritable bowel syndrome (Review)Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients.Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptomsAssociation and symptom characteristics of irritable bowel syndrome among bronchial asthma patients in KuwaitComparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey.Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.Celiac disease in South-West of Iran.Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III.Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?Irritable bowel syndrome: a review article.Health status and management of chronic non-specific abdominal complaints in general practice.What is the relevance of a systematic review of pharmacological management in irritable bowel syndrome to older people? Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.Irritable bowel syndrome. Diagnosis is based on clinical criteria.A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial.Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial.Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndromeDo patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?Manning criteria in irritable bowel syndrome: its diagnostic significance.Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation.Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsIrritable bowel syndrome: diagnosis and pathogenesis.Relationship between irritable bowel syndrome, worry and stress in adolescent girlsRelationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria.Mental Strain and Chronic Stress among University Students with Symptoms of Irritable Bowel Syndrome.Increased glial glutamate transporter EAAT2 expression reduces visceral nociceptive response in miceEffects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study.Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.Health Related Quality of Life in Iranian Patients With Irritable Bowel Syndrome: Reliability and Validity of the Persian Version of the IBS-QOL.Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome.Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial.
P2860
Q21261904-02A013C2-4BF7-40E1-8373-2A80BF8D2E32Q24535897-B6EB1F5C-93AE-4277-944C-EAA962C8B4D2Q26824367-E4EC136F-871A-4128-9455-1F94160277E0Q30855641-9F644A70-EA9E-4245-BAB8-3F775F5CE328Q33235286-687BE389-2D29-41A0-850A-E95C45E36301Q33446254-597BBD90-AC92-4501-967C-C4CA57BDB5E5Q33470938-80E7533E-7818-4F52-AE34-5629CA4FCDCEQ33701309-21DDDCB2-2BBE-4ADB-A48B-5290142F008CQ33730271-E35CF0C5-4E28-4C62-AB5E-3FDFA0E576C7Q33739768-805C6D1B-6639-42DE-89DF-439CD2BE15B8Q33761372-0BE5E139-C536-4A33-946E-4CF06926E6FFQ33780866-D9295072-920F-4670-B219-633C7EC54998Q33867593-8C5061CB-F6F2-4775-9108-12E9CC4E2AA8Q33890272-EC7807CF-375D-4062-95B2-4F563A18C4D2Q33890526-CAEF341D-EA40-45E9-87B0-0985854A8C30Q34098643-C5581812-AA81-4DA5-AA28-74FA0E59308EQ34134491-0FC525CC-EA43-4D1D-AFDD-57A69EFED76EQ34218473-50954B3D-3A8A-4F8B-91CA-72476E27F9FAQ34370877-1ADD9022-B0FB-44F6-8C91-C92B0C603C53Q34786704-471236B7-BD01-48DD-89A4-30F5823B5F72Q35014535-CD06E4A0-EDE4-4CC1-B419-2838B75DDBF6Q35166841-60138A6E-5E19-4330-BA1F-147AF93AB489Q35596886-D7F81970-9D40-456B-9071-B5398F9085A2Q35688614-110B30AD-82FC-4540-945C-DE93295909A4Q35752958-D86503B0-898F-485D-96D8-7AFC03CF3573Q35837381-C8600097-6126-4D8F-8A15-C704C088096AQ35841258-65884736-77A2-4925-9F57-F7E777960AABQ35939042-F9C799BA-4571-4080-9865-2A8B20C07177Q36092886-567275EF-8593-47E7-836E-C78C0E169691Q36207200-E6C126E3-9CB4-412A-A173-4BF29989FB18Q36310403-45FEA22F-C341-461F-AED2-CBB492FB3DF9Q36381951-D712AB11-F8D6-4E12-AED7-6EFAEE1027CFQ36844517-12A57C51-AD99-45B9-8F9D-E491AD4DC7FFQ36969663-2A234264-C2E4-4636-A3FE-36E11489B280Q37086176-0A75603C-8606-4313-BFD1-7C7DBEF7AC40Q37222308-BAFF2227-0721-49DC-86FC-6B45DC902EFCQ37290683-4682EABE-7FD1-4F1B-8EAD-C66BCFB0670CQ37569190-883BDAD6-0A1B-4A02-AC26-97212546092FQ37569891-226637A1-2A58-4D12-A3E1-813C6E1416B5Q37641051-FA245C9C-D1C5-4653-8854-67C9F609E85E
P2860
Irritable bowel syndrome in office-based practice in the United States.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Irritable bowel syndrome in office-based practice in the United States.
@en
type
label
Irritable bowel syndrome in office-based practice in the United States.
@en
prefLabel
Irritable bowel syndrome in office-based practice in the United States.
@en
P1433
P1476
Irritable bowel syndrome in office-based practice in the United States.
@en
P2093
Everhart JE
Renault PF
P304
P356
10.1016/0016-5085(91)90275-P
P407
P577
1991-04-01T00:00:00Z